Work

Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab

Year: 2025

Type: erratum

Source: Acta Neuropathologica

DOI: 10.1007/s00401-025-02855-w

Authors: Lawren VandeVrede, Renaud La Joie, Sheena Horiki, Nidhi S. Mundada, Mary Koestler, Ji-Hye Hwang, Peter A. Ljubenkov, Julio C. Rojas, Gil D. Rabinovici, Adam L. Boxer, William W. Seeley

Institution: University of California, San Francisco

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,990

Funder: National Institute on Aging

Awards: Frontotemporal Dementia: Genes, Images, and Emotions, New Approaches to Dementia Heterogeneity, New Approaches to Dementia Heterogeneity

OpenAlex ID: W4407525721

Cites:

Cited by:

Related to: 10